Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

BIOLIFE SOLUTIONS INC (BLFS)

$29.98 -2.57% NASDAQ: BLFS · 15-min delayed
  • BOTHELL, Washington
  • Public · NASDAQ: BLFS
  • 155 employees
$1.3BMarket cap
$6.2MRevenue · FY2014
-$4.6MNet income
155Employees
BLFSNASDAQ
1989IPO

About BIOLIFE SOLUTIONS INC

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2014
$6.2M
Net income
-$4.6M
Total assets
$405.9M
Market cap
$1.3B
Gross margin
64.6%
Operating margin
-17.3%
Net margin
-4.8%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$96.2M
Cost of revenue
$34.1M
Gross profit
$62.1M
Operating expenses
$78.7M
Operating income
-$16.6M
Income tax
$49.0K
Net income
-$4.6M
EPS (basic)
$-0.09
EPS (diluted)
$-0.10

Balance sheet

Total assets
$405.9M
Current assets
$136.6M
Total liabilities
$34.0M
Current liabilities
$23.0M
Shareholders’ equity
$371.9M

Cash flow

Operating cash flow
$20.1M
Investing cash flow
-$71.5M
Financing cash flow
-$10.9M
Net cash flow
-$62.3M

Statements via Polygon.io (SEC filings)

NASDAQ: BLFS
$29.98 -2.57%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$18.15 $31.15

52-week range

Market cap
$1.3B
EPS (diluted)
$-0.1
Shares outstanding
43.4M
Open
Day range
Prev close
Volume
IPO date
Nov 22, 1989

Biolife Solutions Inc (BLFS) Stock Price

  • Reported a net loss of $4.6M in FY2014.
  • Revenue grew 100% from FY2020 to FY2025.
  • Gross margin of 64.6%, net margin -4.8%.
  • Trading 4% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review BIOLIFE SOLUTIONS INC.

Write a review
Newsroom

News about BIOLIFE SOLUTIONS INC

News & sentiment via Polygon.io

FAQ

Biolife Solutions Inc: frequently asked questions

Is Biolife Solutions Inc an American company?

Biolife Solutions Inc is a US-based company headquartered in Bothell, Washington, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Biolife Solutions Inc headquartered?

Biolife Solutions Inc is headquartered in Bothell, Washington, United States.

Is Biolife Solutions Inc publicly traded?

Yes — Biolife Solutions Inc is a publicly traded company. Its stock trades under the ticker symbol BLFS on the NASDAQ.

What does Biolife Solutions Inc do?

Biolife Solutions Inc is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →